Maria Luisa Brandi

Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis

Jean‐Yves Reginster, H. W. Minne, O. H. Sørensen et al. · Osteoporosis International · 2000 · 1.6K citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

Kenneth G. Saag, Jeffrey Petersen, Maria Luisa Brandi et al. · New England Journal of Medicine · 2017 · 1.5K citations · Full text

Medicine, Orthopedic Surgery, Bone Augmentation +16

Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop

John P. Bilezikian, Maria Luisa Brandi, Richard Eastell et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 1.3K citations · Full text

Medicine, Endocrinology, Internal Medicine +16

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

Henry G. Bone, Rachel B. Wagman, Maria Luisa Brandi et al. · The Lancet Diabetes & Endocrinology · 2017 · 961 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density

Ian R. Reid, Jacques P. Brown, P. Burckhardt et al. · New England Journal of Medicine · 2002 · 876 citations · Full text

Medicine, Pharmacotherapy, Bioavailability +12